Signature Estate & Investment Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,336
| Closed | -$231K | – | 566 |
|
|
2024
Q3 | $231K | Buy |
2,336
+125
| +6% | +$12.4K | 0.01% | 470 |
|
|
2024
Q2 | $205K | Buy |
+2,211
| New | +$205K | 0.01% | 485 |
|
|
2020
Q1 | – | Sell |
-3,965
| Closed | -$377K | – | 166 |
|
|
2019
Q4 | $377K | Hold |
3,965
| – | – | 0.02% | 121 |
|
|
2019
Q3 | $302K | Sell |
3,965
-1,206
| -23% | -$91.9K | 0.02% | 132 |
|
|
2019
Q2 | $454K | Buy |
5,171
+2,438
| +89% | +$214K | 0.03% | 116 |
|
|
2019
Q1 | $247K | Sell |
2,733
-7,015
| -72% | -$634K | 0.02% | 144 |
|
|
2018
Q4 | $699K | Buy |
9,748
+2,440
| +33% | +$175K | 0.06% | 108 |
|
|
2018
Q3 | $701K | Buy |
7,308
+1,205
| +20% | +$116K | 0.06% | 96 |
|
|
2018
Q2 | $581K | Sell |
6,103
-530
| -8% | -$50.5K | 0.05% | 104 |
|
|
2018
Q1 | $582K | Buy |
6,633
+337
| +5% | +$29.6K | 0.06% | 103 |
|
|
2017
Q4 | $534K | Sell |
6,296
-1,550
| -20% | -$131K | 0.05% | 113 |
|
|
2017
Q3 | $679K | Sell |
7,846
-598
| -7% | -$51.8K | 0.08% | 96 |
|
|
2017
Q2 | $652K | Buy |
8,444
+297
| +4% | +$22.9K | 0.08% | 81 |
|
|
2017
Q1 | $565K | Buy |
8,147
+1,518
| +23% | +$105K | 0.07% | 87 |
|
|
2016
Q4 | $392K | Buy |
6,629
+1,777
| +37% | +$105K | 0.05% | 91 |
|
|
2016
Q3 | $322K | Hold |
4,852
| – | – | 0.05% | 98 |
|
|
2016
Q2 | $262K | Buy |
+4,852
| New | +$262K | 0.04% | 103 |
|